Fig. 4From: Edoxaban versus enoxaparin for the prevention of venous thromboembolism after total knee or hip arthroplasty: pooled analysis of coagulation biomarkers and primary efficacy and safety endpoints from two phase 3 trialsIncidence of major and CRNM bleeding events. aChi square test; CI = confidence interval; CRNM = clinically relevant nonmajorBack to article page